S. Strandjord

发表

Ganglioside GD2 specific monoclonal antibody 3F8: a phase I study in patients with neuroblastoma and malignant melanoma.

N. Berger, N. Cheung, H. Lazarus, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Detection of neuroblastoma cells in bone marrow using GD2 specific monoclonal antibodies.

D. V. Von Hoff, N. Cheung, P. Coccia, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Reduction of contact factors in sickle cell disease.

P. Coccia, S. Strandjord, J. Simon, 1985, The Journal of pediatrics.

Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results.

B. Files, W. Waugh, C. Daeschner, 2001, Journal of the National Medical Association.

Origin of leukemic relapse after bone marrow transplantation: comparison of cytogenetic and molecular analyses.

P. Zimmerman, B. Blazar, P. Coccia, 1989, Blood.

Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescents.

D. Weisenburger, J. Armitage, P. Bierman, 1992, Blood.

Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.

N. Cheung, P. Coccia, S. Strandjord, 1985, The American journal of pediatric hematology/oncology.

Stomatologic complications of bone marrow transplantation in a pediatric population.

N. Cheung, P. Coccia, S. Strandjord, 1987, Pediatric dentistry.

Oral complications associated with bone marrow transplantation in a pediatric population.

P. Coccia, S. Strandjord, E. Gordon, 1983, The American journal of pediatric hematology/oncology.

Neutrophil elastase produces 52-kD and 30-kD glucocorticoid receptor fragments in the cytosol of human leukemia cells

C. Distelhorst, K. Janiga, S. Strandjord, 1987 .

Neutrophil elastase produces 52-kD and 30-kD glucocorticoid receptor fragments in the cytosol of human leukemia cells.

C. Distelhorst, K. Janiga, S. Strandjord, 1987, Blood.

Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia.

D. Weisenburger, J. Armitage, A. Kessinger, 1989, Bone marrow transplantation.

Incidence of acute graft-versus-host disease with and without methotrexate prophylaxis in allogeneic bone marrow transplant patients.

J. Graham-Pole, N. Cheung, T. Spitzer, 1984, Blood.

High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission.

N. Cheung, P. Coccia, R. Herzig, 1988, Blood.

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.

J. Graham-Pole, H. Lazarus, P. Coccia, 1983, Journal of Clinical Oncology.

Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates.

P. Coccia, S. Strandjord, E. Gordon, 1983, The Journal of pediatrics.

Reassessment of patient response to monoclonal antibody 3F8.

N. Berger, H. Lazarus, F. Miraldi, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Developmental orofacial deficits associated with multimodal cancer therapy: case report.

P. Spalding, P. Coccia, S. Strandjord, 1989, Pediatric dentistry.

Cerebellar toxicity with high-dose cytosine arabinoside.

H. Lazarus, P. Coccia, D. Adelstein, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation

E. Bayever, S. Strandjord, M. Abromowitch, 1997, Bone Marrow Transplantation.

Full hematopoietic engraftment after allogeneic bone marrow transplantation without cytoreduction in a child with severe combined immunodeficiency.

W. Sanger, S. Pirruccello, P. Coccia, 2001, Blood.

In vitro treatment of autologous bone marrow for neuroblastoma patients with anti GD2 monoclonal antibody and human complement: a pilot study.

D. V. Von Hoff, N. Cheung, S. Gerson, 1988, Progress in clinical and biological research.

High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma.

J. Graham-Pole, H. Lazarus, P. Coccia, 1984, The American journal of pediatric hematology/oncology.

Bone marrow transplantation with high-dose cytosine arabinoside.

J. Graham-Pole, H. Lazarus, P. Coccia, 1982, Medical and pediatric oncology.

Bone marrow transplantation in Hunter syndrome: a preliminary report.

P. Coccia, S. Strandjord, P. Warkentin, 1986, Birth defects original article series.

High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumors

J. Garvin, P. Coccia, S. Goldman, 2000, Bone Marrow Transplantation.

Bone marrow transplantation for acute leukemia and lymphoma with high-dose cytosine arabinoside and total body irradiation.

J. Fay, J. Graham-Pole, N. Cheung, 1985, Seminars in oncology.

Development of neuroblastoma monoclonal antibodies for potential utilization in diagnosis and therapy.

N. Cheung, F. Miraldi, P. Coccia, 1985, Progress in clinical and biological research.